SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Ascletis Pharma Files HKEX Return on Share Buyback for Cancellation

Ascletis Pharma filed an HKEX return announcing a share buyback for cancellation.

Related stories